XBI Holdings
State Street SPDR S&P Biotech ETF
1W: -0.4%
1M: -6.6%
3M: -3.9%
YTD: +27.1%
1Y: +52.4%
3Y: +109.2%
5Y: +18.7%
$154.43
-0.08 (-0.05%)
Weekly Expected Move ±3.6%
$143
$149
$154
$160
$165
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$8.1B
Holdings159
Top 10 Wt16.7%
Beta1.10
% Profitable18%
Coverage98%
Portfolio Valuation
P/E54.9
P/B10.4
P/S8.0
EV/EBITDA29.2
P/FCF28.1
PEG3.30
Profitability & Returns
Gross Margin76.7%
Net Margin3.5%
ROE4.7%
ROA1.6%
ROIC8.8%
Div Yield0.12%
Leverage & Liquidity
Debt/Equity1.18
Debt/Assets0.39
Net Debt/EBITDA1.5x
Interest Cov2.9x
Current Ratio1.81
Quick Ratio1.58
Growth (YoY)
Revenue+32.8%
Net Income-4.7%
EPS+5.8%
FCF+2.1%
EBITDA+0.4%
Rev CAGR 3Y+75.2%
Quality Scores
Piotroski F4.0
Altman Z19.26
IS Quality53.6
IS Overall46.8
IS Value36.8
Median P/E-5.8
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 156 | 99.1% | -10.3 |
| Financial Services | 1 | 0.7% | — |
| Other | 10 | 0.2% | — |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 50 of 167 holdings
· Page 1 of 4
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | TWIST BIOSCIENCE CORP | TWST | 2.21% | $232.0M | 1,177,281 | -85.0 | $11.7B | Healthcare |
| 2 | MODERNA INC | MRNA | 2.04% | $214.0M | 1,089,652 | -23.8 | $75.4B | Healthcare |
| 3 | NATERA INC | NTRA | 1.80% | $188.6M | 447,420 | -301.7 | $58.8B | Healthcare |
| 4 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 1.62% | $170.0M | 11,251,093 | -20.3 | $6.3B | Healthcare |
| 5 | AMGEN INC | AMGN | 1.55% | $162.4M | 377,675 | 24.8 | $217.5B | Healthcare |
| 6 | BIOGEN INC | BIIB | 1.54% | $161.5M | 701,205 | 38.7 | $32.5B | Healthcare |
| 7 | UNITED THERAPEUTICS CORP | UTHR | 1.54% | $161.1M | 291,574 | 17.9 | $23.0B | Healthcare |
| 8 | ABBVIE INC | ABBV | 1.50% | $157.1M | 588,960 | 74.0 | $464.3B | Healthcare |
| 9 | HALOZYME THERAPEUTICS INC | HALO | 1.48% | $154.9M | 1,375,999 | 31.2 | $13.0B | Healthcare |
| 10 | SPYRE THERAPEUTICS INC | SYRE | 1.47% | $154.3M | 1,699,846 | -47.8 | $8.1B | Healthcare |
| 11 | GILEAD SCIENCES INC | GILD | 1.47% | $154.2M | 1,014,570 | -55.7 | $179.5B | Healthcare |
| 12 | TG THERAPEUTICS INC | TGTX | 1.47% | $153.8M | 2,703,952 | 17.8 | $8.3B | Healthcare |
| 13 | CRISPR THERAPEUTICS AG | CRSP | 1.46% | $153.3M | 2,716,415 | -11.6 | $5.3B | Healthcare |
| 14 | VERTEX PHARMACEUTICALS INC | VRTX | 1.44% | $151.2M | 283,566 | 29.1 | $128.1B | Healthcare |
| 15 | EXELIXIS INC | EXEL | 1.44% | $150.9M | 2,533,309 | 17.7 | $14.7B | Healthcare |
| 16 | REVOLUTION MEDICINES INC | RVMD | 1.42% | $149.0M | 711,572 | -23.3 | $43.9B | Healthcare |
| 17 | PROTAGONIST THERAPEUTICS INC | PTGX | 1.39% | $145.6M | 1,013,552 | 115.0 | $9.0B | Healthcare |
| 18 | INCYTE CORP | INCY | 1.38% | $145.1M | 1,172,663 | 14.2 | $23.4B | Healthcare |
| 19 | PTC THERAPEUTICS INC | PTCT | 1.38% | $144.5M | 2,186,953 | -129.5 | $5.3B | Healthcare |
| 20 | ALNYLAM PHARMACEUTICALS INC | ALNY | 1.37% | $144.1M | 572,764 | 36.0 | $29.4B | Healthcare |
| 21 | KRYSTAL BIOTECH INC | KRYS | 1.37% | $144.0M | 424,521 | 39.0 | $9.5B | Healthcare |
| 22 | REGENERON PHARMACEUTICALS | REGN | 1.35% | $141.5M | 182,964 | 17.6 | $75.7B | Healthcare |
| 23 | BIOMARIN PHARMACEUTICAL INC | BMRN | 1.34% | $140.4M | 2,294,182 | 150.5 | $11.1B | Healthcare |
| 24 | GRAIL INC | GRAL | 1.33% | $139.9M | 979,351 | -14.7 | $6.1B | Healthcare |
| 25 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1.32% | $138.9M | 270,288 | -38.7 | $11.5B | Healthcare |
| 26 | NEUROCRINE BIOSCIENCES INC | NBIX | 1.31% | $137.8M | 952,485 | 20.3 | $14.4B | Healthcare |
| 27 | ORUKA THERAPEUTICS INC | ORKA | 1.31% | $137.2M | 1,614,957 | -34.2 | $5.1B | Healthcare |
| 28 | ALKERMES PLC | ALKS | 1.28% | $134.5M | 3,254,864 | 103.6 | $7.0B | Healthcare |
| 29 | CYTOKINETICS INC | CYTK | 1.28% | $134.0M | 1,994,008 | -9.1 | $8.2B | Healthcare |
| 30 | TRAVERE THERAPEUTICS INC | TVTX | 1.28% | $134.0M | 2,231,509 | -126.5 | $5.3B | Healthcare |
| 31 | INSMED INC | INSM | 1.27% | $133.5M | 1,147,271 | -27.0 | $24.1B | Healthcare |
| 32 | ROIVANT SCIENCES LTD | ROIV | 1.26% | $131.8M | 3,534,417 | -94.0 | $25.8B | Healthcare |
| 33 | BRIDGEBIO PHARMA INC | BBIO | 1.24% | $130.3M | 1,942,329 | -18.8 | $13.2B | Healthcare |
| 34 | COGENT BIOSCIENCES INC | COGT | 1.21% | $127.4M | 3,900,938 | -13.4 | $5.3B | Healthcare |
| 35 | PRAXIS PRECISION MEDICINES I | PRAX | 1.21% | $127.1M | 427,949 | -22.8 | $8.2B | Healthcare |
| 36 | ERASCA INC | ERAS | 1.19% | $125.3M | 8,381,324 | -15.5 | $5.1B | Healthcare |
| 37 | DIANTHUS THERAPEUTICS INC | DNTH | 1.18% | $124.0M | 1,380,523 | -678.5 | $4.9B | Healthcare |
| 38 | KODIAK SCIENCES INC | KOD | 1.18% | $123.9M | 1,281,918 | -22.5 | $5.9B | Healthcare |
| 39 | KYMERA THERAPEUTICS INC | KYMR | 1.16% | $122.0M | 1,070,109 | -33.0 | $8.8B | Healthcare |
| 40 | IONIS PHARMACEUTICALS INC | IONS | 1.14% | $120.1M | 2,637,881 | -12.6 | $7.2B | Healthcare |
| 41 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 1.14% | $119.4M | 1,788,396 | -28.7 | $9.0B | Healthcare |
| 42 | VAXCYTE INC | PCVX | 1.10% | $115.5M | 1,990,365 | -7.4 | $8.2B | Healthcare |
| 43 | RHYTHM PHARMACEUTICALS INC | RYTM | 1.10% | $115.0M | 1,184,359 | -29.8 | $6.4B | Healthcare |
| 44 | VIKING THERAPEUTICS INC | VKTX | 1.09% | $114.5M | 3,444,940 | -6.4 | $3.5B | Healthcare |
| 45 | IMMUNITYBIO INC | IBRX | 1.07% | $112.7M | 11,702,382 | -10.6 | $10.8B | Healthcare |
| 46 | CG ONCOLOGY INC | CGON | 1.06% | $111.5M | 1,541,674 | -25.0 | $5.9B | Healthcare |
| 47 | VERACYTE INC | VCYT | 1.04% | $109.5M | 2,332,081 | 31.8 | $3.7B | Healthcare |
| 48 | MIRUM PHARMACEUTICALS INC | MIRM | 1.02% | $107.1M | 1,229,029 | -5.7 | $5.1B | Healthcare |
| 49 | TANGO THERAPEUTICS INC | TNGX | 0.99% | $103.4M | 4,065,305 | -27.3 | $3.8B | Healthcare |
| 50 | CELCUITY INC | CELC | 0.93% | $97.1M | 1,197,169 | -16.8 | $3.5B | Healthcare |